• About Us
    • List of Regulators
    • News Websites
  • What We Do
    • Downloads
  • Mission
  • Vision
  • Contact Us
  • Terms of use
  • Privacy Policy
  • Disclaimer
Investadvocate
  • Home
  • Business News
    • Capital Market
    • Money Market
    • Fraud & Scandals
    • Results & Dividends
  • Updates
  • Investors Bite
  • World News
  • Trending
  • Over-the-Counter Beat
  • Q & A Session

All Posts in "Frauds & Scandals"

SEC Charges Florida Microcap Company, CEO and Consultant with Fraud

September 28, 2018/US SEC The Securities and Exchange Commission today charged a Florida-based microcap issuer,…
by InvestAdvocate — September 28, 2018 in Frauds & Scandals 0
SEC Charges Salix Pharmaceuticals and Former CFO With Lying About Distribution Channel

SEC Charges Salix Pharmaceuticals and Former CFO With Lying About Distribution Channel

September 28, 2018/US SEC The Securities and Exchange Commission today charged Salix Pharmaceuticals Ltd. and…
by InvestAdvocate — September 28, 2018 in Frauds & Scandals 0

SEC Charges Australia-Based Investment Adviser with Fraud

September 28, 2018/US SEC The Securities and Exchange Commission filed charges against an Australia-based investment…
by InvestAdvocate — September 28, 2018 in Frauds & Scandals 0

Posts pagination

Previous 1 … 647 648 649 … 1,045 Next
WEEKLY TOP GAINERS
COYOPENING PRICECLOSING PRICE% CHG
UPDCREIT 10.65 14.20+33.33%
FBNH959.95120.50+25.59%
UNILEVER124.00147.95+19.31%
CADBURY   57.00  67.50+18.42%
AXAMANS    11.20   13.20+17.86%
WEEKLY TOP LOSERS
COYOPENING PRICECLOSING PRICE% CHG
MECURE85.4562.40-26.97%
ROYALEX   1.48  1.29-12.84%
TRIPLGE    3.89   3.41-12.34%
SUNUASR    4.00     3.60-10.00%
BUAFOODS939.00845.10-10.00%

Source: NGX as at July 24, 2026

APO NEWSROOM

Follow Investadvocate on Twitter

Tweets by @investadvocate

Regulators Links

 

NGX

SEC

CBN

EFCC

CSCS

NDIC

MORE

 

TV Stations

 

CNN

AlJazeera

TVC News

AIT

Channels TV

BBC

CNBC

News Websites

 

Yahoo! News 

Premier League

The Will 

Proshare

Huhuonline

Financial Times 

More

 

opan

 

 

© 2026 Investadvocate ·